about
The Concise Guide to PHARMACOLOGY 2013/14: ion channelsPrevention of ventilator-induced lung edema by inhalation of nanoparticles releasing ruthenium red.Optimization of a Novel Series of TRPV4 Antagonists with In Vivo Activity in a Model of Pulmonary EdemaActivation of Transient Receptor Potential Vanilloid 4 Impairs the Dendritic Arborization of Newborn Neurons in the Hippocampal Dentate Gyrus through the AMPK and Akt Signaling Pathwaysα1- and α2-adrenergic responsiveness in human skeletal muscle feed arteries: the role of TRPV ion channels in heat-induced sympatholysisTRPV4 and AQP4 Channels Synergistically Regulate Cell Volume and Calcium Homeostasis in Retinal Müller Glia.TRPV4 as a therapeutic target for joint diseases.Blockage of transient receptor potential vanilloid 4 inhibits brain edema in middle cerebral artery occlusion mice.Activation of transient receptor potential vanilloid 4 induces apoptosis in hippocampus through downregulating PI3K/Akt and upregulating p38 MAPK signaling pathways.TRPV4 associates environmental temperature and sex determination in the American alligatorTRPV4 and the regulation of vascular toneUVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signalingTransient Receptor Potential Vanilloid 4 Inhibits γ-Aminobutyric Acid-Activated Current in Hippocampal Pyramidal Neurons.Enhanced Oxidative Stress Is Responsible for TRPV4-Induced NeurotoxicityNew strategies to develop novel pain therapies: addressing thermoreceptors from different points of view.Potential Future Pharmacological Treatment of Bladder Dysfunction.Direct measurement of TRPV4 and PIEZO1 activity reveals multiple mechanotransduction pathways in chondrocytes.Mitochondrial VDAC and hexokinase together modulate plant programmed cell death.TRPV4 Antagonists: Potential Treatment for Congestive Heart Failure, Bladder Dysfunctions, and Pain.Concurrent shear stress and chemical stimulation of mechano-sensitive cells by discontinuous dielectrophoresis.Regulated phosphorylation of the K-Cl cotransporter KCC3 is a molecular switch of intracellular potassium content and cell volume homeostasis.TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein.TRPV4 activates autonomic and behavioural warmth-defence responses in Wistar rats.Heteromeric TRPV4/TRPC1 channels mediate calcium-sensing receptor-induced nitric oxide production and vasorelaxation in rabbit mesenteric arteries.Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference.Interplay among distinct Ca2+ conductances drives Ca2+ sparks/spontaneous transient outward currents in rat cerebral arteries.Expression of transient receptor potential vanilloid 4 and effects of ruthenium red on detrusor overactivity associated with bladder outlet obstruction in rats.When size matters: transient receptor potential vanilloid 4 channel as a volume-sensor rather than an osmo-sensor.Endothelial Ca2+ Signaling and the Resistance to Anticancer Treatments: Partners in Crime.Transient Receptor Potential Vanilloid 4-Induced Modulation of Voltage-Gated Sodium Channels in Hippocampal Neurons.Activation of Transient Receptor Potential Vanilloid 4 is Involved in Neuronal Injury in Middle Cerebral Artery Occlusion in Mice.Drugs Affecting TRP Channels.Increased Expression of Transient Receptor Potential Vanilloid 4 in Cortical Lesions of Patients with Focal Cortical Dysplasia.
P2860
Q30486735-A2C501FE-F06D-4F4B-9069-03152305F279Q30581469-5636F0DA-98E3-4823-8BBC-9491A83EA916Q33636002-0607A51E-7FC0-4D73-B54E-C4CEF16764A3Q33799760-66B8978B-5B78-40D8-BC40-B25651536BD2Q34439954-692609E2-0E97-4CA5-9CCA-088FD95D9EA2Q34496425-A1838A6A-D6B5-4C1A-9DDA-5FBC81C1C6B5Q35181627-179D9F2E-767B-473C-BC6D-D79FCA4CA66EQ35352503-15768E2D-E4F5-4F39-8974-6DE18DE19752Q36347329-2D33761E-D129-4D52-B41D-BF616EBBA8B5Q36382597-9A51E240-E6B3-4290-8D71-ACCDCC1A28B7Q36589012-BF8881D0-28F6-4CA8-95A2-B37A0EFC2BF8Q37117917-F653AC55-4C38-4AFD-836D-39AF8AC4633EQ37208116-3A62F0A4-FA57-4809-A4EC-DE2B7048F2DAQ37342469-A45B26F4-8298-4B97-97B3-EF17BDCC65BDQ38167283-CAAA2978-9B90-49AE-882C-F55D33CA9D3DQ38779624-8E4158EA-A25D-43D3-9FF2-ADA0841CE5CAQ38992046-C87EDC5F-3FC7-4B5D-B9B6-66FA8DE20B6BQ39224642-16A40D47-BCEA-4422-983D-6CA63B972C51Q39779578-BCDDD861-D058-4913-A8E6-281FD8BD767DQ40000771-BDBB2381-7EC0-494F-910F-32D0B381CA22Q40688751-6EB41D06-C490-453F-8177-48E76E0D3D01Q41098513-7952F6F7-AC2F-4746-B7A3-CB4ABCB56165Q41295546-9848F7F3-D403-4B9D-A345-569662C070B4Q41959176-BF1B61F3-66FB-4270-B9C8-D06968436C17Q42375985-442268B3-0515-498D-87D5-8054D379B6A5Q43756991-585B30FE-8BE0-4430-B5E7-ED8EC992C410Q44005162-61DFDD21-EAB5-4E93-ABC5-011BC5C1F63FQ47228512-DD2DEC89-DE37-4C9B-A82E-08395E64C0CCQ48260240-E2BE434B-E55F-433D-845D-B7581E3335C9Q48414139-0EA9510E-06DE-40DD-AE9C-FE51D68EEFDFQ48455462-D415871D-BD98-4041-A48A-9378024A8DAEQ51058589-B9167C0D-D6DC-4B1B-91C5-24ABB15A9F0DQ53185404-23416980-6B87-4E8E-A836-09459674D1B7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
TRPV4 agonists and antagonists.
@ast
TRPV4 agonists and antagonists.
@en
TRPV4 agonists and antagonists.
@nl
type
label
TRPV4 agonists and antagonists.
@ast
TRPV4 agonists and antagonists.
@en
TRPV4 agonists and antagonists.
@nl
prefLabel
TRPV4 agonists and antagonists.
@ast
TRPV4 agonists and antagonists.
@en
TRPV4 agonists and antagonists.
@nl
P1476
TRPV4 agonists and antagonists.
@en
P2093
Fabien Vincent
Matthew A J Duncton
P304
P356
10.2174/156802611796904861
P577
2011-01-01T00:00:00Z